English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduWhat’s the best way to communicate with a vaccine-hesitant person about a vaccine’s potential benefits? New research from Binghamton University, State University of New York found that a one-size-fits-all approach to communicating messages isn’t effective.
Tag: covid 19
COVID-19-induced financial hardships reveal mental health struggles
Economic researchers at the University of South Australia have examined the mental health effects on people who experienced financial setbacks during the height of the COVID-19 pandemic.
Testing environmental water to monitor COVID-19 spread in unsheltered encampments
To better understand COVID-19’s spread during the pandemic, public health officials expanded wastewater surveillance. These efforts track SARS-CoV-2 levels and health risks among most people, but they miss people who live without shelter, a population particularly vulnerable to severe infection.
MSU co-authored study: 10 insights to reduce vaccine hesitancy on social media
Young Anna Argyris, associate professor in the Michigan State University Department of Media and Information, is part of an international team studying the detrimental effects of vaccine misinformation on social media and interventions that can increase vaccine uptake behaviors.
Mount Sinai Receives $2.6 Million Grant From PolyBio Research Foundation for Long COVID Clinical Trials
Funding will also support researching other complex illnesses and medical education
Covid vaccine for pregnant women safe for newborn infants
No increased risks for babies, and for some serious neonatal complications lower risks.
Distance education during pandemic led to less care for mental ill health
Upper secondary school students were less likely to seek help for mental ill health when they were forced to study at home during the pandemic.
Machine learning to battle COVID-19 bacterial co-infection
University of Queensland researchers have used machine learning to help predict the risk of secondary bacterial infections in hospitalised COVID-19 patients.
Long COVID most prevalent in the most seriously ill
Severe physical symptoms persist for up to two years in people who had a severe COVID-19 infection, highlighting the importance of long-term monitoring.
How to slow the spread of deadly ‘superbugs’
Harnessing new advances in genomic surveillance technology could help detect the rise of deadly ‘superbugs’
Preventing airborne infection without impeding communication with ions and electric field
Researchers in Tokyo developed a device using ions and an electric field to capture infectious droplets and aerosols, allowing communication while preventing airborne infection
How long should kids isolate after they’ve contracted COVID-19?
School policies that require students with COVID-19 to stay out of the classroom for five days are more than sufficient.
Common symptoms of COVID-19 and often-overlooked symptoms
Carol Nwelue, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. COVID-19 has been around for three years now. What are some of the recent common symptoms we are seeing? (SOT@…
People with Long COVID Have Distinct Hormonal and Immune Differences From Those Without This Condition
Research conducted at Mount Sinai and Yale confirms long COVID is a biological disease by showing blood biomarkers that can predict who has it
Dr. Marc Elieson discusses concerns about COVID-19 and kids going back to school
Marc Elieson, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. The CDC says COVID cases will continue to increase this summer and when school resumes this fall. What is behind…
Variable patient responses to SARS-CoV-2 infection are mimicked in genetically diverse mice
Researchers at The Jackson Laboratory have created a panel of genetically diverse mice that accurately model the highly variable human response to SARS-CoV-2 infection.
Gastrointestinal viruses all but disappeared during COVID—but surged back two years on
Following the first stay-at-home orders issued in the U.S. to curb the spread of COVID-19, gastrointestinal viruses such as norovirus, rotavirus and adenovirus all but disappeared from California communities, and remained at very low levels for nearly 2 years.
One year post-COVID-19 mass vaccination, immunization coverage is higher among those eligible for priority vaccination
At the beginning of the mass vaccination against COVID-19 infection, the government had to determine eligibility for priority vaccination.
Mimicking the body’s own defenses to destroy enveloped viruses
Viruses often mutate or hide themselves within cells. But by mimicking the way the immune system naturally deals with invaders, researchers reporting in ACS Infectious Diseases have developed a “peptoid” antiviral therapy that effectively inactivates three viruses in lab tests.
COVID-19 Vaccines: What Parents Need to Know Now
The coronavirus pandemic is no longer a national emergency, but the virus that causes COVID-19 isn’t gone—and neither is the risk of getting the disease. For parents, navigating when to get their child vaccinated and knowing how to best protect their child from COVID-19 can be complicated. We spoke to Michael Smit, MD, MSPH, Hospital Epidemiologist and Medical Director of Infection Prevention and Control at Children’s Hospital Los Angeles, to get an update on the latest COVID-19 vaccine information and precautions.
UV disinfection in the treatment management of SARS-CoV-2 Omicron variants
The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its new variants has created a need for effective disinfection technologies to protect against harmful pathogens. While vaccines offer some protection, their effectiveness against future variants is uncertain. Therefore, additional strategies are important during the pre-vaccine stage.
Some people’s brain function still affected by Long COVID years after infection
UK researchers have found that people with longer-term COVID-19 symptoms including brain fog showed reduced performance in tasks testing different mental processes up to two years after infection with the virus.
Study finds similar health outcomes for pregnant patients receiving in-person prenatal care or a combination of virtual and in-office visits
Pregnant patients who received some of their prenatal care during the COVID-19 pandemic in a combination of virtual and in-office visits — known as multimodal prenatal care — had similar health outcomes as those who were seen mostly in person before the pandemic
Poignant photo project reveals all we lost in lockdown
As the UK Covid inquiry continues for a fifth week, researchers at the University of East Anglia have created a unique snapshot of lockdown life.
Hospital Understaffing and Poor Work Conditions Associated with Physician and Nurse Burnout and Intent to Leave
A unique collaborative study on hospital clinician wellbeing by teams at 60 of the nation’s best hospitals, defined by Magnet Hospital Recognition, was published today in JAMA Health Forum. The study found that physicians and nurses, even at hospitals known to be good places to work, experienced adverse outcomes during the pandemic and want hospital management to make significant improvements in their work environments and in patient safety. The solutions to high hospital clinician burnout and turnover, they say, are not resilience training for clinicians to better cope with adverse working conditions but organizational improvements that provide safe workloads and better work-life balance.
Wastewater monitoring could act as pandemic early warning system
Wastewater monitoring could act as an early warning system to help countries better prepare for future pandemics, according to a new study.
Monitoring British bats can help identify coronaviruses with pathogen potential
Researchers who found novel coronaviruses in UK bats say genetic surveys of the viruses should be regularly conducted, even if none of those viruses can infect humans yet.
People who preserve ‘immune resilience’ live longer, resist infections
Researchers from The University of Texas Health Science Center at San Antonio, working with collaborators in five countries, today revealed that the capacity to resist or recover from infections and other sources of inflammatory stress — called “immune resilience” — differs widely among individuals.
Lung and heart stem cell research paves way for new COVID-19 treatments
Researchers have used heart and lung stem cells infected with the virus that causes COVID-19 to better understand how the disease impacts different organs, paving the way for more targeted treatments.
Four state policies linked to growth of telehealth at mental health facilities
Four state policies introduced during the COVID-19 pandemic to spur expansion of telehealth were associated with expansion of such services by mental health facilities, but growth of telehealth was lower among facilities in counties with the greatest proportion of Black residents, according to a new RAND Corporation study.
Study shows metformin lowers the risk of getting long COVID
In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.
Long Covid can impact fatigue and quality of life worse than some cancers
Fatigue is the symptom that most significantly impacts the daily lives of long Covid patients, and can affect quality of life more than some cancers, finds a new study led by researchers at UCL and the University of Exeter.
COVID-19 can cause brain cells to fuse
Researchers at The University of Queensland have discovered viruses such as SARS-CoV-2 can cause brain cells to fuse, initiating malfunctions that lead to chronic neurological symptoms.
Antipsychotic drugs use increased in Canadian long-term care homes in first year of pandemic
While most aspects of care quality in long-term care homes did not differ in the first year of the pandemic from pre-pandemic levels, a new study shows that the use of antipsychotic drugs increased in all provinces.
Study reveals novel action mechanism of corticosteroids in combating inflammation caused by COVID-19
Since the start of the COVID-19 pandemic, a class of corticosteroids called glucocorticoids (GCs) have become established as one of the main treatment options, especially for severe cases, thanks to their anti-inflammatory and immunosuppressant action. Brazilian researchers recently discovered new ways in which these drugs influence the organism’s inflammatory response during an infection.
New research sheds light on the causes of fatigue after COVID 19
Experts from Newcastle University found the nervous system of people with post-Covid fatigue was underactive in three key areas. Fatigue is one of the most common symptoms of long Covid.
Sleep apnea associated with increased risk for long COVID
Sleep apnea may significantly increase the risk for long COVID in adults, according to a study led by the National Institutes of Health’s RECOVER Initiative and supported by NYU Langone Health as home to the effort’s Clinical Science Core (CSC).
Risk of long COVID higher for people living in most deprived areas
New research led by the universities of Southampton and Oxford has found that the risk of long COVID is strongly associated with area-level deprivation, with the odds of having long COVID 46 percent higher for people from the most deprived areas, compared to those in the least deprived areas.
Cognitive behavioral therapy lessens post-viral fatigue after COVID-19
Those with post-viral fatigue after suffering from COVID-19 benefit from cognitive behavioural therapy, resulting in less fatigue and concentration problems.
Occludin protein plays key role in spread of coronavirus throughout body’s cells
While the coronavirus continues to infect people around the world, researchers at the University of Missouri have identified a specific protein inside the human body that plays a critical role in how the virus spreads from cell to cell after infection — a discovery that will help better understand the COVID-19 disease and could lead to the development of new antiviral drugs in the future.
Finnish population-based study: Vulnerable groups were the least likely to uptake COVID-19 vaccination
A large-scale registry study in Finland has identified several factors associated with uptake of the first dose of COVID-19 vaccination. In particular, persons with low or no labor income and persons with mental health or substance abuse issues were less likely to vaccinate.
Infectious SARS-CoV-2 found in hospital air
Quebec scientists have succeeded in isolating infectious particles of the SARS-CoV-2 virus from air samples collected from hospital rooms of COVID-19 patients and kept frozen for more than a year, a new study shows.
Study provides evidence that peer-support groups can be beneficial in reducing healthcare worker stress and burnout
A pilot study examining the feasibility, receptivity and preliminary effectiveness of peer-support groups for ED doctors during COVID-19 found this support provided potential benefit in terms of reduction of mental health stresses involved in emergency care during this time.
Children with COVID-19 treated safely at home, helping to take burden off hospitals
Children with COVID-19 can be treated safely at home, helping to take the burden off the hospital system, according to a new study.
The potential and challenges of mucosal COVID-19 vaccines
In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop have now been published as a report in npj Vaccines.
Durability of bivalent boosters against Omicron subvariants
New research led by the UNC Gillings School of Global Public Health shows that bivalent COVID-19 boosters are still providing effective protection from hospitalization and death, even against the most recent omicron subvariants.
Study offers insights into how COVID variants escape immune system ‘killers’
Omicron subvariants of SARS-CoV-2 — the virus behind COVID-19 — have shown an uncanny knack for evading antibodies produced either by vaccines or exposure to earlier versions of the virus, leading to many breakthrough infections. However, in order to sicken people, these viral variants must also avoid “killer” T cells, immune cells that are unleashed when the immune system detects foreign pathogens.
Vaccine hesitancy has become a nationwide issue: What can science do about it?
South Carolina residents were more hesitant than Americans as a whole to receive the COVID-19 vaccine during the fall of 2020, report researchers in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC) in the Journal of Psychiatry Research.
Alcohol screening rates dropped substantially during the first COVID-19 surge
New research from Boston Medical Center found that alcohol screening rates dropped substantially during the first COVID-19 surge.
Researchers find an antibody that targets omicron and other SARS-CoV-2 variants
A team led by researchers at Weill Cornell Medicine, the University of Wisconsin-Madison; Scripps Research and the University of Chicago has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including Omicron, the most recent. Their discovery could lead to more potent vaccines and new antibody-based treatments.